Plasma levels of Rifampicin and Pyrazinamide with pre and post meal administration in tuberculosis patients

Joshi, 2011, Tuberculosis chemotherapy in the 21st century: back to the basics, Lung India, 28, 193, 10.4103/0970-2113.83977 Raviglione, 2006, XDR-TB: entering the post-antibiotic era?, Int J Tuberc Lung Dis, 10, 1185 Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi. Revised National Tuberculosis Control Programme DOTS-Plus Guidelines. Available from: health.bih.nic.in/Docs/Guidelines/Guidelines-DOTS-Plus.pdf [accessed 15.09.16]. Turner, 1994, Serum drug levels in tuberculosis patients, Am J Respir Crit Care Med, 149, A527 Peloquin, 1993, Malabsorption of antimicrobial medications, N Engl J Med, 329, 1122, 10.1056/NEJM199310073291513 Burhan, 2013, Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients, Antimicrob Agents Chemother, 57, 3614, 10.1128/AAC.02468-12 Pablos-Mendez, 1998, Global surveillance for antituberculosis drug resistance 1994–1997, N Engl J Med, 338, 1641, 10.1056/NEJM199806043382301 Morehead, 2000, Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic levels, South Med J, 93, 507, 10.1097/00007611-200093050-00015 Kimerling, 1998, Low serum antimicrobacterial drug levels in non-HIV-infected tuberculosis patients, Chest, 113, 1178, 10.1378/chest.113.5.1178 Barakat, 1996, Grand rounds-Hammersmith Hospital: persistent fever in pulmonary tuberculosis, BMJ, 313, 1543, 10.1136/bmj.313.7071.1543 Peloquin, 2002, Therapeutic drug monitoring in the treatment of tuberculosis, Drugs, 62, 2169, 10.2165/00003495-200262150-00001 Holdiness, 1984, Clinical pharmacokinetics of the antituberculosis drugs, Clin Pharmacokinet, 9, 511, 10.2165/00003088-198409060-00003 Peloquin, 1997, Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide, Antimicrob Agents Chemother, 41, 2670, 10.1128/AAC.41.12.2670 Long, 1979, U.S. Public Health Service cooperative trial of three rifampin–isoniazid regimens in treatment of tuberculosis, Am Rev Respir Dis, 119, 879 Sirgel, 2005, The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis, Am J Respir Crit Care Med, 172, 128, 10.1164/rccm.200411-1557OC Gumbo, 2007, Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin, Antimicrob Agents Chemother, 51, 3781, 10.1128/AAC.01533-06 Fahimi, 2013, Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6h post dose in patients with pulmonary tuberculosis, Int J Tuberc Lung Dis, 17, 1602, 10.5588/ijtld.13.0019 McIlleron, 2006, Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients, Antimicrob Agents Chemother, 50, 1170, 10.1128/AAC.50.4.1170-1177.2006